Terms: = Head and neck cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Treatment
171 results:
1. Palbociclib inhibits the progression of head and neck cancer and improves the Cetuximab response under specific condition in vitro and in vivo.
Li R; Wang Q; Zhao Y; Zhu Y; Wang X
Mol Biol Rep; 2024 Mar; 51(1):455. PubMed ID: 38536540
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
3. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
[TBL] [Abstract] [Full Text] [Related]
4. Hellebrigenin induces oral cancer cell apoptosis by modulating MAPK signalling and XIAP expression.
Hsieh MJ; Lin CC; Lo YS; Ho HY; Chuang YC; Chen MK
J Cell Mol Med; 2024 Jan; 28(2):e18071. PubMed ID: 38044583
[TBL] [Abstract] [Full Text] [Related]
5. cdk4 phosphorylation status and rational use for combining cdk4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Pita JM; Raspé E; Coulonval K; Decaussin-Petrucci M; Tarabichi M; Dom G; Libert F; Craciun L; Andry G; Wicquart L; Leteurtre E; Trésallet C; Marlow LA; Copland JA; Durante C; Maenhaut C; Cavaco BM; Dumont JE; Costante G; Roger PP
Front Endocrinol (Lausanne); 2023; 14():1247542. PubMed ID: 37964967
[TBL] [Abstract] [Full Text] [Related]
6. Poor oral health influences head and neck cancer patient survival: an International head and neck cancer Epidemiology Consortium pooled analysis.
Tasoulas J; Farquhar DR; Sheth S; Hackman T; Yarbrough WG; Agala CB; Koric A; Giraldi L; Fabianova E; Lissowska J; Świątkowska B; Vilensky M; Wünsch-Filho V; de Carvalho MB; López RVM; Holcátová I; Serraino D; Polesel J; Canova C; Richiardi L; Zevallos JP; Ness A; Pring M; Thomas SJ; Dudding T; Lee YA; Hashibe M; Boffetta P; Olshan AF; Divaris K; Amelio AL
J Natl Cancer Inst; 2024 Jan; 116(1):105-114. PubMed ID: 37725515
[TBL] [Abstract] [Full Text] [Related]
7. Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic head and neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial.
Keam B; Hong MH; Shin SH; Heo SG; Kim JE; Ahn HK; Lee YG; Park KU; Yun T; Lee KW; Kim SB; Lee SC; Kim MK; Cho SH; Oh SY; Park SG; Hwang S; Nam BH; Kim S; Kim HR; Yun HJ;
J Clin Oncol; 2024 Feb; 42(5):507-517. PubMed ID: 37699162
[TBL] [Abstract] [Full Text] [Related]
8. Evolving role of novel radiosensitizers and immune checkpoint inhibitors in (chemo)radiotherapy of locally advanced head and neck squamous cell carcinoma.
Ngamphaiboon N; Chairoungdua A; Dajsakdipon T; Jiarpinitnun C
Oral Oncol; 2023 Oct; 145():106520. PubMed ID: 37467684
[TBL] [Abstract] [Full Text] [Related]
9. p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.
Bai F; Liu X; Zhang X; Mao Z; Wen H; Ma J; Pei XH
Cell Cycle; 2023 Jul; 22(13):1637-1653. PubMed ID: 37345432
[TBL] [Abstract] [Full Text] [Related]
10. Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Zhang P; Zhang Q; Tong Z; Sun T; Li W; Ouyang Q; Hu X; Cheng Y; Yan M; Pan Y; Teng Y; Yan X; Wang Y; Xie W; Zeng X; Wang X; Hu C; Geng C; Zhang H; Li W; Wu X; Zhong J; Xu J; Shi Y; Wei W; Bayaxi N; Zhu X; Xu B
Lancet Oncol; 2023 Jun; 24(6):646-657. PubMed ID: 37182538
[TBL] [Abstract] [Full Text] [Related]
11. cdk4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas.
Duah E; Seligson ND; Persaud AK; Dam Q; Pabla N; Rocco JW; Li J; Poi M
Mol Carcinog; 2023 Aug; 62(8):1201-1212. PubMed ID: 37132760
[TBL] [Abstract] [Full Text] [Related]
12. Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors.
Zhang X; Wang Y; Zhang X; Shen Y; Yang K; Ma Q; Qiao Y; Shi J; Wang Y; Xu L; Yang B; Ge G; Hu L; Kong X; Yang C; Chen Y; Ding J; Meng L
Signal Transduct Target Ther; 2023 Apr; 8(1):153. PubMed ID: 37041169
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Impact of Metastatic Lymph Node Size on Therapeutic Effect and Prognosis in Patients with Esophageal Squamous Cell Carcinoma Who Underwent Preoperative Chemotherapy Followed by Esophagectomy.
Sugimura K; Miyata H; Kanemura T; Takeoka T; Sugase T; Yamamoto M; Shinnno N; Hara H; Omori T; Motoori M; Ohue M; Yano M
Ann Surg Oncol; 2023 Jul; 30(7):4193-4202. PubMed ID: 37010661
[TBL] [Abstract] [Full Text] [Related]
14. Differentiated Thyroid cancer in Adolescents: Single Center Experience and Considerations for Surgical Management and Radioiodine treatment.
Chiapponi C; Hartmann MJM; Decarolis B; Simon T; Bruns CJ; Faust M; Schultheis AM; Schmidt M; Alakus H
J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):257-263. PubMed ID: 36987773
[TBL] [Abstract] [Full Text] [Related]
15. First Reported Case of Malignant Ectomesenchymoma with p.Leu122Arg Mutation in MYOD1 Gene: Extensive Intra- and Extracranial Tumor in a 15-Year-Old Female.
Pena-Burgos EM; De Sabando DP; Utrilla C; Pozo-Kreilinger JJ; Sastre A; Rubio P; Escudero A; Mendiola-Sabio M; Pérez-Martínez A
Head Neck Pathol; 2023 Sep; 17(3):855-863. PubMed ID: 36913073
[TBL] [Abstract] [Full Text] [Related]
16. The effects of Abemaciclib on cell cycle and apoptosis regulation in anaplastic thyroid cancer cells.
Abutorabi ES; Poursheikhani A; Kashani B; Shamsaiegahkani S; Haghpanah V; Bashash D; Mousavi SA; Momeny M; Ghaffari SH
Mol Biol Rep; 2023 May; 50(5):4073-4082. PubMed ID: 36877344
[TBL] [Abstract] [Full Text] [Related]
17. Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1.
Liu X; Jiang Y; Zhou H; Zhao X; Li M; Bao Z; Wang Z; Zhang C; Xie Z; Zhao J; Dong Z; Liu K; Guo Z
Cell Death Dis; 2023 Feb; 14(2):118. PubMed ID: 36781836
[TBL] [Abstract] [Full Text] [Related]
18. DNA Damage Response Gene Signature as Potential treatment Markers for Oral Squamous Cell Carcinoma.
Pomella S; Cassandri M; Melaiu O; Marampon F; Gargari M; Campanella V; Rota R; Barillari G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768994
[TBL] [Abstract] [Full Text] [Related]
19. [A case report of adult primary soft tissue sarcoma of the head and neck].
Liu L; Qiu H; Hui M; Jiang F; Wang D; Lin Y; Yang X; Yao J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Feb; 37(2):146-149. PubMed ID: 36756833
[No Abstract] [Full Text] [Related]
20. HSF1 activates the FOXO3a-ΔNp63α-cdk4 axis to promote head and neck squamous cell carcinoma cell proliferation and tumour growth.
Wang Y; Zhu Q; Guo S; Ao J; Zhang W; Fei J; Yu S; Niu M; Zhang Y; Sherman MY; Xiao ZJ; Yi Y
FEBS Lett; 2023 Apr; 597(8):1125-1137. PubMed ID: 36700826
[TBL] [Abstract] [Full Text] [Related]
[Next]
